Zhejiang Hisun Pharmaceutical Co., Ltd. at its directorate meeting on September 20, 2012, approved the proposal of appointing Chen Wende as Senior Vice President.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.73 CNY | -0.26% | -2.03% | -17.41% |
20/05 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
16/05 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.41% | 125.7Cr | |
+41.92% | 74TCr | |
+32.52% | 60TCr | |
-5.65% | 35TCr | |
+16.97% | 32TCr | |
+4.33% | 28TCr | |
+16.34% | 24TCr | |
+9.66% | 21TCr | |
-5.24% | 21TCr | |
+7.36% | 16TCr |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd. Appoints Chen Wende as Senior Vice President